Hover a dot or row, or tab through the dots · bars scaled to the largest round ($173M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-410506
First filed2021-08-18
Latest2021-08-18
Sought$201M
Sold$173M
Investors14
Exemptions506(b)
021-371966
First filed2020-07-28
Latest2020-09-14
Sought$33.7M
Sold$33.7M
Investors15
Exemptions506(b)
021-323741
First filed2018-10-17
Latest2019-11-08
Sought$8M
Sold$7.5M
Investors10
Exemptions506(b)
Who backs Venn Biosciences Corp — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-08-18
Related persons
Name
Relationship
Aldo Carrascoso
RelationshipExecutive Officer, Director
Jenny Rooke
RelationshipDirector
David Michael
RelationshipDirector
Facts
As its latest Form D states them
Industry
Biotechnology
State
California (CA)
Exemptions
Rule 506(b)
First filed
2018-10-17
Latest filing
2021-08-18
Who backs Venn Biosciences Corp
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)